Hennessy (HNNA) Form 4: Director reports two sales totaling 5,301 shares
Rhea-AI Filing Summary
Thomas L. Seavey, a director of Hennessy Advisors, Inc. (HNNA), reported two open-market sales of company common stock on August 14 and August 15, 2025. The Form 4 shows sales of 2,698 shares on 08/14/2025 at a weighted average price of $10.7036 and 2,603 shares on 08/15/2025 at a weighted average price of $10.6331. After the reported transactions, Mr. Seavey beneficially owned 50,424 shares directly. The Form 4 was signed by Teresa M. Nilsen as attorney-in-fact on 08/18/2025. The filing notes the reported prices are weighted averages with price ranges disclosed for each sale.
Positive
- Transparency: Sales reported with weighted-average prices and disclosed price ranges.
- Ongoing ownership: Reporting person continues to hold a substantial direct stake of 50,424 shares after transactions.
Negative
- Insider selling: Director sold a total of 5,301 shares across two days.
- No 10b5-1 designation indicated: The form does not check the box indicating the transactions were pursuant to a pre-arranged trading plan.
Insights
TL;DR: Director executed modest open-market sales totaling 5,301 shares; retains a sizable direct stake of 50,424 shares.
The transactions reported are routine open-market disposals rather than derivative exercises or transfers. Total shares sold were 5,301 across two days at weighted average prices of $10.7036 and $10.6331, with disclosed price ranges. From an investor-impact perspective, these sales do not by themselves indicate company-wide financial change; they reduce the director's direct holdings but he remains a substantial shareholder. Reporting was completed by an attorney-in-fact as required.
TL;DR: Insider disclosures appear compliant and timely; sales were reported and signed by an authorized attorney-in-fact.
The Form 4 identifies Mr. Seavey as a director and indicates the filing was made by one reporting person. The inclusion of weighted-average price ranges and an explanatory note supports transparency. No indication of Rule 10b5-1 plan designation is checked on the form. The filings are routine governance disclosures; materiality to investors depends on context not provided in this form.